Company: LNAI
Filing Date: 2025-05-15
Form Type: 10-Q
Source: 0001731122-25-000765
Chunk: 20

Company: Lunai Bioworks Inc.
Filing Date: 2025-05-15
Form: 10-Q
Item: Part I, Item 1
Chunk 20
---
 31, 2025 and $1,050,000 matured on January 31, 2025. On February 24, 2025, Paseco ApS assigned 50% of
its ownership rights to Laksya Ventures Inc. with all terms remaining unchanged. The note balance at March 31, 2025, was $2,650,000 with
Paseco ApS and Laksya Ventures Inc. each holding $1,325,000.

From November 12, 2024 to December
3, 2024, Renovaro Cube entered into an agreement with Paseco ApS, a Danish entity controlled by a shareholder (“Paseco ApS”),
to issue Promissory Notes for the principal amount of €500,000. The note bears an interest rate of 10% per annum and matures on December
1, 2025. During the period ended March 31, 2025 approximately €50,000 was reclassed to accounts payable. On February 24, 2025 Paseco
ApS assigned 50% of its ownership rights to Laksya Ventures Inc. with all terms remaining unchanged. The note balance at March 31, 2025
was approximately $490,000 with Paseco ApS and Laksya Ventures Inc. each holding $245,000.

On November 1, 2024, Renovaro Cube
entered into an agreement with Yalla Yalla Limited, an investor to issue a Promissory Note for the amount of approximately €230,000.
The note bears an interest rate of 10% per annum and matured on February 24, 2025. The note balance at March 31, 2025 was approximately
$238,000.

On September 16, 2024, the Company
entered into an agreement with RS Bio ApS, a Danish entity controlled by a shareholder (“RS Bio”), to issue a Promissory Note
for the principal amount of $100,000 (the “September 2024 Note”). The Company received $100,000 in gross proceeds. The note
bears an interest rate of 12% per annum and matured on December 31, 2024. On February 24, 2025 RS Bio assigned its ownership rights to
Rene Sindlev with all terms remaining unchanged. The note balance at March 31, 2025 was $100,000.

On September